A randomized, double-blind, placebo-controlled trial of metformin in reducing progression among men on expectant management for low-risk prostate cancer: The MAST (Metformin Active Surveillance Trial) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback